Citius Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 05/09/2025 | 257.63 K | $383.87 K | 0.00% | 2.22% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 89.28 K | $133.05 K | 16.69% | 0.77% |
BLACKROCK, INC. | 05/02/2025 | 72.23 K | $107.62 K | 0.00% | 0.62% |
UBS GROUP AG | 05/13/2025 | 67.22 K | $100.15 K | 143.82% | 0.58% |
SQUAREPOINT OPS LLC | 05/15/2025 | 60.98 K | $90.87 K | 22.78% | 0.53% |
STATE STREET CORP | 05/15/2025 | 23.27 K | $34.67 K | 0.00% | 0.20% |
CITADEL ADVISORS LLC | 05/15/2025 | 18.78 K | $27.98 K | 164.66% | 0.16% |
NORTHERN TRUST CORP | 05/13/2025 | 15.17 K | $22.61 K | 18.79% | 0.13% |
BAY COLONY ADVISORY GROUP, INC D/B/A BAY COLONY ADVISORS | 04/21/2025 | 14.00 K | $21.70 K | 100.00% | 0.12% |
ARKADIOS WEALTH ADVISORS | 05/08/2025 | 10.00 K | $14.90 K | 0.00% | 0.09% |
CITADEL ADVISORS LLC | 05/15/2025 | 9.80 K | $14.60 K | -61.78% | 0.08% |
IFP ADVISORS, INC | 05/05/2025 | 7.08 K | $10.55 K | 0.00% | 0.06% |
CHELSEA COUNSEL CO | 05/22/2025 | 4.63 K | $6.89 K | 100.00% | 0.04% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 4.41 K | $6.57 K | -46.30% | 0.04% |
GROUP ONE TRADING, L.P. | 05/14/2025 | 3.34 K | $4.98 K | -30.62% | 0.03% |
05/02/2025 | 2.27 K | $3.38 K | -0.61% | 0.02% | |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 1.53 K | $2.27 K | 0.00% | 0.01% |
SIMPLEX TRADING, LLC | 05/12/2025 | 966 | $1.00 K | -43.84% | 0.01% |
05/14/2025 | 435 | $522 | 27.94% | 0.00% | |
PRINCETON GLOBAL ASSET MANAGEMENT LLC | 04/11/2025 | 160 | $238 | 0.00% | 0.00% |
05/14/2025 | 160 | $238 | 0.00% | 0.00% | |
JPMORGAN CHASE & CO | 05/12/2025 | 136 | $203 | 9.68% | 0.00% |
SMALLWOOD WEALTH INVESTMENT MANAGEMENT, LLC | 04/25/2025 | 120 | $178 | 100.00% | 0.00% |
QUENT CAPITAL, LLC | 04/04/2025 | 108 | $161 | 0.00% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 107 | $159 | -11.57% | 0.00% |
FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 05/15/2025 | 80 | $119 | 100.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 68 | $101 | 23.64% | 0.00% |
MORGAN STANLEY | 05/15/2025 | 60 | $89 | -81.13% | 0.00% |
FAIRSCALE CAPITAL, LLC | 05/14/2025 | 42 | $63 | -88.52% | 0.00% |
CITIGROUP INC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
FISHER ASSET MANAGEMENT, LLC | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
ROYAL BANK OF CANADA | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
CITADEL ADVISORS LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
IFP ADVISORS, INC | 05/05/2025 | 0 | $0 | -100.00% | 0.00% |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
RONALD BLUE TRUST, INC. | 04/21/2025 | 0 | $0 | -100.00% | 0.00% |
Citius Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 30 institutional investors and hedge funds held shares of Citius Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Quent Capital, LLC: 0
SIMPLEX TRADING, LLC: 0
UBS Group AG: 67,215
Squarepoint Ops LLC: 60,983
STATE STREET CORP: 23,271
NORTHERN TRUST CORP: 15,173
5.48% of Citius Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.39 M shares in the last 24 months. This purchase volume represents approximately $3.10 M in transactions.